Home › Funds › ACT CAPITAL MANAGEMENT, LLC › KRYS

ACT CAPITAL MANAGEMENT, LLC position in KRYS

KRYSTAL BIOTECH INC · Health Care

ACT CAPITAL MANAGEMENT, LLC reported holding 45,000 shares of KRYS (KRYSTAL BIOTECH INC) in its Q2 2026 13F filing — a position valued at US$16.7M, representing 10.93% of its reported portfolio and ranking #1 among its reported holdings. ACT CAPITAL MANAGEMENT, LLC has disclosed KRYS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)45.00K sh
Reported value held$16.73M
Portfolio Weight10.93%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ACT CAPITAL MANAGEMENT, LLC's KRYS position evolved

ACT CAPITAL MANAGEMENT, LLC first disclosed a stake in KRYS in Q4 2025 at 60,500 shares (US$14.9M). The position peaked in Q2 2026 at 45,000 shares, worth US$16.7M. Across 3 filings, ACT CAPITAL MANAGEMENT, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 45,000 shares valued at US$16.7M — a reduction of -15,477 shares quarter over quarter.. Notable position changes include a 26% trim in Q2 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 60.50K $14.92M New
Q1 2026 60.48K $15.62M Hold
Q2 2026 45.00K $16.73M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KRYS and 13F data

KRYS (KRYSTAL BIOTECH INC) is a Health Care company. 49 other funds we track also report a position in KRYS — the largest reported positions include Avoro Capital Advisors LLC (US$1.07B), Soleus Capital Management, L.P. (US$349.1M), Hood River Capital Management LLC (US$246.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KRYS

All KRYS fund holders →

FAQ

How long has ACT CAPITAL MANAGEMENT, LLC held KRYS?

ACT CAPITAL MANAGEMENT, LLC has disclosed KRYS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is ACT CAPITAL MANAGEMENT, LLC's current position in KRYS?

As of Q2 2026, ACT CAPITAL MANAGEMENT, LLC holds 45.00K shares of KRYS (KRYSTAL BIOTECH INC), valued at $16.73M, representing 10.93% of its reported portfolio and ranking #1.

Has ACT CAPITAL MANAGEMENT, LLC been buying or selling KRYS?

In the latest 13F filing (Q2 2026), ACT CAPITAL MANAGEMENT, LLC reduced its position in KRYS. The position peaked in Q2 2026 at 45.00K shares.

Which other funds hold KRYS?

Other major institutional holders of KRYS include Avoro Capital Advisors LLC, Soleus Capital Management, L.P., Hood River Capital Management LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.